Drug intelligence / Profile preview

buxue ningshen tablets

Development stage: Unknown
Lead developer: Jingxin Pharmaceutical
Administration: Oral

Overview

Buxue Ningshen Tablets (补血宁神片) is a Traditional Chinese Medicine (TCM) product developed and manufactured by Zhejiang Jingxin Pharmaceutical. It is primarily indicated for the treatment of anemia and insomnia, conditions often associated in TCM with blood deficiency and mental restlessness. The formulation typically consists of botanical extracts designed to nourish the blood and soothe the nerves. The product is approved for marketing in China and is listed in the company's pharmaceutical pipeline as a therapeutic for hematological and neurological symptoms.

Brand names: Buxue Ningshen Tablets
Other names: 补血宁神片Buxue Ningshen Pian

Beyond the preview

Go deeper on buxue ningshen tablets.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on buxue ningshen tablets.

Explore the full profile